当前位置: 首页 >> 检索结果
共有 38500 条符合本次的查询结果, 用时 4.5946429 秒

1661. One Sunday Morning.

作者: Richard Scott Morehead.
来源: Chest. 2022年162卷6期1338-1339页

1662. Medical Student and Trainee Notes in the Electronic Health Record Era.

作者: Lindsay A Stevens.;Natalie M Pageler.;Christopher A Longhurst.
来源: Chest. 2022年162卷6期1238-1240页

1663. The Intersection of Ventilatory Strategy to Prevent Atelectasis and Teslas in Navigational Bronchoscopy.

作者: Robert J Lentz.;Samira Shojaee.
来源: Chest. 2022年162卷6期1236-1237页

1664. Insight Ventilation Perfusion Inefficiency in Patients With Heart Failure With Preserved Ejection Fraction.

作者: Fabiana De Martino.;Piergiuseppe Agostoni.
来源: Chest. 2022年162卷6期1233-1235页

1665. Intravitreal Bevacizumab for Retinopathy of Prematurity: Another Hit to the Immature Lung?

作者: Ignacio Oulego-Erroz.;Almudena Alonso-Ojembarrena.
来源: Chest. 2022年162卷6期1231-1232页

1666. Exploring the Lung-Gut Nexus.

作者: Aman Pande.
来源: Chest. 2022年162卷6期1229-1230页

1667. Maintenance Pulmonary Rehabilitation: Can We Keep the Good Times Rolling?

作者: Sanjay Ramakrishnan.
来源: Chest. 2022年162卷6期1227-1228页

1668. What Do Adults With Cystic Fibrosis Want From Their Doctors?

作者: Pierre-Régis Burgel.
来源: Chest. 2022年162卷6期1225-1226页

1669. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.

作者: Yuling Qian.;Ruilin Quan.;Xiaoxi Chen.;Qing Gu.;Changming Xiong.;Huijun Han.;Gangcheng Zhang.;Yucheng Chen.;Zaixin Yu.;Hongyan Tian.;Yuhao Liu.;Xianyang Zhu.;Shengqing Li.;Caojin Zhang.;Jianguo He.
来源: Chest. 2023年163卷6期1531-1542页
Registry-based studies of pediatric pulmonary arterial hypertension (PPAH) are scarce in developing countries, including China. The PPAH risk assessment tool needs further evaluation and improvement.

1670. Remote Monitoring of Positive Airway Pressure Data: Challenges, Pitfalls, and Strategies to Consider for Optimal Data Science Applications.

作者: Guillaume Bottaz-Bosson.;Alphanie Midelet.;Monique Mendelson.;Jean-Christian Borel.;Jean-Benoît Martinot.;Ronan Le Hy.;Marie-Caroline Schaeffer.;Adeline Samson.;Agnès Hamon.;Renaud Tamisier.;Atul Malhotra.;Jean-Louis Pépin.;Sébastien Bailly.
来源: Chest. 2023年163卷5期1279-1291页
Over recent years, positive airway pressure (PAP) remote monitoring has transformed the management of OSA and produced a large amount of data. Accumulated PAP data provide valuable and objective information regarding patient treatment adherence and efficiency. However, the majority of studies that have analyzed longitudinal PAP remote monitoring have summarized data trajectories in static and simplistic metrics for PAP adherence and the residual apnea-hypopnea index by the use of mean or median values. The aims of this article are to suggest directions for improving data cleaning and processing and to address major concerns for the following data science applications: (1) conditions for residual apnea-hypopnea index reliability, (2) lack of standardization of indicators provided by different PAP models, (3) missing values, and (4) consideration of treatment interruptions. To allow fair comparison among studies and to avoid biases in computation, PAP data processing and management should be conducted rigorously with these points in mind. PAP remote monitoring data contain a wealth of information that currently is underused in the field of sleep research. Improving the quality and standardizing data handling could facilitate data sharing among specialists worldwide and enable artificial intelligence strategies to be applied in the field of sleep apnea.

1671. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.

作者: Scott M Matson.;Misbah Baqir.;Teng Moua.;Michael Marll.;Jessica Kent.;Nicholas S Iannazzo.;Ryan D Boente.;John M Donatelli.;Junqiang Dai.;Francisco J Diaz.;M Kristen Demoruelle.;Mark B Hamblin.;Susan K Mathai.;Jay H Ryu.;Kristen Pope.;Christopher M Walker.;Joyce S Lee.
来源: Chest. 2023年163卷4期861-869页
Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is common in patients with RA and leads to significant morbidity and mortality. No randomized, placebo-controlled data are available that support the role of immunosuppression to treat RA-associated ILD, despite being widely used in clinical practice.

1672. Higher Work of Breathing During Exercise in Heart Failure With Preserved Ejection Fraction.

作者: Nicolas Villarraga.;Brit Warner.;Eric J Bruhn.;Shane M Hammer.;Thomas G Bissen.;Thomas P Olson.;Joshua R Smith.
来源: Chest. 2023年163卷6期1492-1505页
It is unknown if pulmonary alterations in heart failure with preserved ejection fraction (HFpEF) impact respiratory mechanics during exercise.

1673. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.

作者: Felipe V C Machado.;Claus F Vogelmeier.;Rudolf A Jörres.;Henrik Watz.;Robert Bals.;Tobias Welte.;Martijn A Spruit.;Peter Alter.;Frits M E Franssen.
来源: Chest. 2023年163卷5期1071-1083页
Alterations in body composition, including a low fat-free mass index (FFMI), are common in patients with COPD and occur regardless of body weight.

1674. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.

作者: Sahrish Shah.;Tarek Nayfeh.;Bashar Hasan.;Meritxell Urtecho.;Mohammed Firwana.;Samer Saadi.;Rami Abd-Rabu.;Ahmad Nanaa.;David N Flynn.;Noora S Rajjoub.;Walid Hazem.;Mohamed O Seisa.;Leslie C Hassett.;Alex C Spyropoulos.;James D Douketis.;M Hassan Murad.
来源: Chest. 2023年163卷5期1245-1257页
The management of patients who are receiving chronic oral anticoagulation therapy and require an elective surgery or an invasive procedure is a common clinical scenario.

1675. Emphysema Quantifications With CT Scan: Assessing the Effects of Acquisition Protocols and Imaging Parameters Using Virtual Imaging Trials.

作者: Ehsan Abadi.;Giavanna Jadick.;David A Lynch.;W Paul Segars.;Ehsan Samei.
来源: Chest. 2023年163卷5期1084-1100页
CT scan has notable potential to quantify the severity and progression of emphysema in patients. Such quantification should ideally reflect the true attributes and pathologic conditions of subjects, not scanner parameters. To achieve such an objective, the effects of the scanner conditions need to be understood so the influence can be mitigated.

1676. Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets.

作者: Jean Baptiste Lascarrou.;Florence Dumas.;Wulfran Bougouin.;Stephane Legriel.;Nadia Aissaoui.;Nicolas Deye.;Frankie Beganton.;Lionel Lamhaut.;Daniel Jost.;Antoine Vieillard-Baron.;Graham Nichol.;Eloi Marijon.;Xavier Jouven.;Alain Cariou.; .
来源: Chest. 2023年163卷5期1120-1129页
Recent guidelines have emphasized actively avoiding fever to improve outcomes in patients who are comatose following resuscitation from cardiac arrest (ie, out-of-hospital cardiac arrest). However, whether targeted temperature management between 32 °C and 36 °C (TTM32-36) can improve neurologic outcome in some patients remains debated.

1677. Outpatient Mental Health Follow-up and Recurrent Self-harm and Suicide Among Patients Admitted to the ICU for Self-harm: A Population-based Cohort Study.

作者: Shannon M Fernando.;Michael Pugliese.;Daniel I McIsaac.;Danial Qureshi.;Robert Talarico.;Manish M Sood.;Daniel T Myran.;Margaret S Herridge.;Dale M Needham.;Laveena Munshi.;Bram Rochwerg.;Kirsten M Fiest.;Christina Milani.;Magdalena Kisilewicz.;O Joseph Bienvenu.;Daniel Brodie.;Eddy Fan.;Robert A Fowler.;Niall D Ferguson.;Damon C Scales.;Hannah Wunsch.;Peter Tanuseputro.;Kwadwo Kyeremanteng.
来源: Chest. 2023年163卷4期815-825页
Patients surviving an ICU admission for deliberate self-harm are at high risk of recurrent self-harm or suicide after discharge. It is unknown whether mental health follow-up after discharge (with either a family physician or psychiatrist) reduces this risk.

1678. OSA and Subsequent Risk of Hospitalization With Pneumonia, Respiratory Infection, and Total Infection: The Atherosclerosis Risk in Communities Study.

作者: Pamela L Lutsey.;Islam Zineldin.;Jeffrey R Misialek.;Kelsie M Full.;Kamakshi Lakshminarayan.;Junichi Ishigami.;Logan T Cowan.;Kunihiro Matsushita.;Ryan T Demmer.
来源: Chest. 2023年163卷4期942-952页
OSA has been linked to microaspiration, systemic inflammation, and suboptimal immune function.

1679. Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD.

作者: Ching-Fu Weng.;Chien-Chih Wu.;Mei-Hsuan Wu.;Fang-Ju Lin.
来源: Chest. 2023年163卷4期799-814页
Researchers have yet to obtain conclusive evidence differentiating among fixed-dose combinations (FDCs) of long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs) for COPD in terms of real-world clinical outcomes.

1680. Shape-Sensing Robotic-Assisted Bronchoscopy vs Digital Tomosynthesis-Corrected Electromagnetic Navigation Bronchoscopy: A Comparative Cohort Study of Diagnostic Performance.

作者: See-Wei Low.;Robert J Lentz.;Heidi Chen.;James Katsis.;Matthew C Aboudara.;Samuel Whatley.;Rafael Paez.;Otis B Rickman.;Fabien Maldonado.
来源: Chest. 2023年163卷4期977-984页
Electromagnetic navigational bronchoscopy has been the dominant bronchoscopic technology for targeting small peripheral lesions and now includes digital tomosynthesis-electromagnetic navigational bronchoscopy (DT-ENB), allowing near-real-time intraprocedural nodule visualization. Shape-sensing robotic-assisted bronchoscopy (ssRAB), with improved catheter stability and articulation recently became available. Although the diagnostic performance of these two methods seems higher than that of legacy systems, data remain limited. We sought to compare the diagnostic yield of these two novel platforms after their introduction at our institution.
共有 38500 条符合本次的查询结果, 用时 4.5946429 秒